Pro Share Advisors LLC Immuno Gen, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $252,090 - $605,948	20,232 Added 42.15%	68,227 $2.02 Million
Q3 2023 Nov 13, 2023	SELL	$14.09 - $19.87 $10,764 - $15,180	-764 Reduced 1.57%	47,995 $761,000
Q2 2023 Aug 10, 2023	BUY	$3.75 - $20.05 $30,690 - $164,089	8,184 Added 20.17%	48,759 $920,000
Q1 2023 May 11, 2023	SELL	$3.67 - $4.92 $19,480 - $26,115	-5,308 Reduced 11.57%	40,575 $155,000
Q4 2022 Feb 02, 2023	BUY	$4.55 - $6.31 $16,607 - $23,031	3,650 Added 8.64%	45,883 $227,000
Q3 2022 Nov 04, 2022	BUY	$4.48 - $6.47 $4,206 - $6,075	939 Added 2.27%	42,233 $202,000
Q2 2022 Aug 01, 2022	SELL	$3.15 - $5.76 $68,761 - $125,735	-21,829 Reduced 34.58%	41,294 $185,000
Q1 2022 May 10, 2022	SELL	$4.26 - $7.48 $36,751 - $64,529	-8,627 Reduced 12.02%	63,123 $301,000
Q4 2021 Feb 08, 2022	BUY	$4.75 - $7.5 $15,024 - $23,722	3,163 Added 4.61%	71,750 $533,000
Q3 2021 Nov 12, 2021	SELL	$5.02 - $6.59 $90,505 - $118,811	-18,029 Reduced 20.81%	68,587 $389,000
Q2 2021 Aug 13, 2021	BUY	$5.79 - $8.6 $48,856 - $72,566	8,438 Added 10.79%	86,616 $571,000
Q1 2021 May 14, 2021	BUY	$6.5 - $10.53 $53,833 - $87,209	8,282 Added 11.85%	78,178 $633,000
Q4 2020 Feb 09, 2021	BUY	$3.7 - $7.66 $76,612 - $158,607	20,706 Added 42.09%	69,896 $451,000
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $6,996 - $9,916	-2,028 Reduced 3.96%	49,190 $177,000
Q2 2020 Aug 03, 2020	BUY	$3.32 - $5.34 $57,675 - $92,766	17,372 Added 51.33%	51,218 $236,000
Q1 2020 May 15, 2020	SELL	$2.12 - $6.8 $38,552 - $123,658	-18,185 Reduced 34.95%	33,846 $115,000
Q4 2019 Feb 12, 2020	SELL	$2.25 - $5.8 $11,396 - $29,377	-5,065 Reduced 8.87%	52,031 $266,000
Q3 2019 Nov 12, 2019	SELL	$2.22 - $3.39 $3,893 - $5,946	-1,754 Reduced 2.98%	57,096 $138,000
Q2 2019 Aug 13, 2019	SELL	$1.8 - $3.3 $13,329 - $24,436	-7,405 Reduced 11.18%	58,850 $128,000
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $1,433 - $3,516	595 Added 0.91%	66,255 $180,000
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $49,931 - $122,928	-12,673 Reduced 16.18%	65,660 $315,000
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $47,669 - $62,414	5,543 Added 7.62%	78,333 $742,000
Q2 2018 Aug 13, 2018	SELL	$9.52 - $12.15 $10,700 - $13,656	-1,124 Reduced 1.52%	72,790 $708,000
Q1 2018 May 14, 2018	SELL	$6.7 - $12.95 $81,485 - $157,497	-12,162 Reduced 14.13%	73,914 $778,000
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $436,405 - $681,721	86,076	86,076 $552,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account